Shire, Roche slug it out in billion-dollar haemophilia drug battle

ZURICH (Reuters) - Swiss drugmaker Roche's bid to take a chunk of the $11 billion haemophilia drug market dominated by Shire took another blow with the Irish company winning a preliminary injunction over its Swiss rival's medication.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news